Goulart H, Kantarjian H, Borthakur G, Daver N, et al. Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trial. Cancer 2025;131:e35840.
PMID: 40193193